Associate Professor, uOttawa
Bureau : 613 562 5800 poste 2516
Email : firstname.lastname@example.org
Office : STEM Complex, Room 358
Associate Professor, uOttawa, Faculty of Science, Department of Chemistry & Biomolecular Sciences; University of Ottawa Heart Institute
Dr. Shuhendler is currently an associate professor at the University of Ottawa and holds a Canada Research Chair (Tier 2) in chemical biology. He holds a primary appointment in the Faculty of Science, Department of Chemistry & Biomolecular Sciences, and is cross-appointed to the Department of Biology, the UOHI, and is affiliated with the University of Ottawa Brain and Mind Research Institute where he is a member of the Concussion Injury Group.
Medical imaging technologies, such as magnetic resonance imaging (MRI) and positron emission tomography (PET), have the potential to allow early detection of disease, inflammation or injury, improving the ability to detect disease at early stages. The members of the Molecular Medicine Lab are developing new molecules enabling the visualization of these early signs of disease using these medical imaging technologies. With their efforts, their goal is to provide new clinical tools to achieve better prognoses through earlier diagnosis of a range of diseases and injuries spanning atherosclerosis, concussion, drug toxicity, and disease response to therapeutics.